Buy Glenmark Pharma, advises Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Glenmark Pharma is an exception; it jumped out of a trading range yesterday. So it is a buying opportunity. In fact it was a laggard earlier and it is catching up. Glenmark Pharma is appropriate for buying."

At 11:39 hrs Glenmark Pharma was quoting at Rs 866.20, down Rs 17.80, or 2.01 percent. It has touched an intraday high of Rs 890.10 and an intraday low of Rs 863.05.